1
|
Loterio RK, Rosevear K, Edenborough K, Fraser JE. Complete inactivation of orthoflavi- and alphaviruses by acetone for safe titering by ELISA. J Virol Methods 2025; 335:115146. [PMID: 40056951 DOI: 10.1016/j.jviromet.2025.115146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2025] [Revised: 03/03/2025] [Accepted: 03/05/2025] [Indexed: 04/15/2025]
Abstract
The tissue culture infectious dose 50 (TCID50) end-point dilution assay is the gold-standard assay to titer viruses with negligible or ambiguous cytopathic effects. The assay's specificity is improved when followed by an Enzyme-Linked Immunosorbent Assay (ELISA) to detect viral antigens. Cells infected with mosquito-borne orthoflavi- and alphaviruses are fixed after TCID50, prior to ELISA, using paraformaldehyde (PFA) or acetone. While 4 % PFA has been shown to effectively inactivate these viruses for safe handling in low biocontainment conditions, equivalent studies have not been reported for standard acetone fixation methods (20 % acetone for 24 hours at 4°C). This study evaluated the inactivation efficacy of acetone on orthoflavi- and alphaviruses using dengue virus (DENV) and Ross River virus (RRV), as exemplar viruses from each genus, respectively. We show that 50 % acetone and 4 % PFA fully inactivate DENV and RRV, but 20 % acetone does not reduce the infectivity of these viruses. Importantly, ELISA-based detection of DENV- and RRV-infected cells fixed with 50 % acetone was effective, with calculated titres comparable to cells treated with 20 % acetone. Together, our results inform a fixation method for titrating orthoflavi- and alphavirus samples by TCID50/ELISA, ensuring the safe handling and processing of these viruses under low biocontainment conditions.
Collapse
Affiliation(s)
- Robson K Loterio
- Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton Campus, Victoria, Australia.
| | - Katherine Rosevear
- Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton Campus, Victoria, Australia
| | - Kathryn Edenborough
- Department of Infectious Diseases, Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
| | - Johanna E Fraser
- Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton Campus, Victoria, Australia
| |
Collapse
|
2
|
Barbosa AD, Long M, Lee W, Austen JM, Cunneen M, Ratchford A, Burns B, Kumarasinghe P, Ben-Othman R, Kollmann TR, Stewart CR, Beaman M, Parry R, Hall R, Tabor A, O’Donovan J, Faddy HM, Collins M, Cheng AC, Stenos J, Graves S, Oskam CL, Ryan UM, Irwin PJ. The Troublesome Ticks Research Protocol: Developing a Comprehensive, Multidiscipline Research Plan for Investigating Human Tick-Associated Disease in Australia. Pathogens 2022; 11:1290. [PMID: 36365042 PMCID: PMC9694322 DOI: 10.3390/pathogens11111290] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Revised: 10/23/2022] [Accepted: 11/02/2022] [Indexed: 10/28/2023] Open
Abstract
In Australia, there is a paucity of data about the extent and impact of zoonotic tick-related illnesses. Even less is understood about a multifaceted illness referred to as Debilitating Symptom Complexes Attributed to Ticks (DSCATT). Here, we describe a research plan for investigating the aetiology, pathophysiology, and clinical outcomes of human tick-associated disease in Australia. Our approach focuses on the transmission of potential pathogens and the immunological responses of the patient after a tick bite. The protocol is strengthened by prospective data collection, the recruitment of two external matched control groups, and sophisticated integrative data analysis which, collectively, will allow the robust demonstration of associations between a tick bite and the development of clinical and pathological abnormalities. Various laboratory analyses are performed including metagenomics to investigate the potential transmission of bacteria, protozoa and/or viruses during tick bite. In addition, multi-omics technology is applied to investigate links between host immune responses and potential infectious and non-infectious disease causations. Psychometric profiling is also used to investigate whether psychological attributes influence symptom development. This research will fill important knowledge gaps about tick-borne diseases. Ultimately, we hope the results will promote improved diagnostic outcomes, and inform the safe management and treatment of patients bitten by ticks in Australia.
Collapse
Affiliation(s)
- Amanda D. Barbosa
- Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, WA 6150, Australia
- CAPES Foundation, Ministry of Education of Brazil, Brasilia 70040-020, DF, Brazil
| | - Michelle Long
- Australian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, VIC 3220, Australia
| | - Wenna Lee
- Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, WA 6150, Australia
| | - Jill M. Austen
- Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, WA 6150, Australia
| | - Mike Cunneen
- The App Workshop Pty Ltd., Perth, WA 6000, Australia
| | - Andrew Ratchford
- Emergency Department, Northern Beaches Hospital, Sydney, NSW 2086, Australia
- School of Medicine, Macquarie University, Sydney, NSW 2109, Australia
| | - Brian Burns
- Emergency Department, Northern Beaches Hospital, Sydney, NSW 2086, Australia
- Sydney Medical School, Sydney University, Camperdown, NSW 2006, Australia
| | - Prasad Kumarasinghe
- School of Medicine, University of Western Australia, Crawley, WA 6009, Australia
- College of Science, Health, Education and Engineering, Murdoch University, Murdoch, WA 6150, Australia
- Western Dermatology, Hollywood Medical Centre, Nedlands, WA 6009, Australia
| | | | | | - Cameron R. Stewart
- CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, VIC 3220, Australia
| | - Miles Beaman
- PathWest Laboratory Medicine, Murdoch, WA 6150, Australia
- Pathology and Laboratory Medicine, Medical School, University of Western Australia, Crawley, WA 6009, Australia
- School of Medicine, University of Notre Dame Australia, Fremantle, WA 6160, Australia
| | - Rhys Parry
- School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia
| | - Roy Hall
- School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD 4072, Australia
- Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072, Australia
| | - Ala Tabor
- Queensland Alliance for Agriculture and Food Innovation, Centre of Animal Science, University of Queensland, St. Lucia, QLD 4072, Australia
| | - Justine O’Donovan
- Clinical Services and Research, Australian Red Cross Lifeblood, Sydney, NSW 2015, Australia
| | - Helen M. Faddy
- Clinical Services and Research, Australian Red Cross Lifeblood, Sydney, NSW 2015, Australia
- School of Health and Behavioural Sciences, University of the Sunshine Coast, Petrie, QLD 4502, Australia
| | - Marjorie Collins
- School of Psychology, Murdoch University, Murdoch, WA 6150, Australia
| | - Allen C. Cheng
- School of Public Health and Preventive Medicine, Monash University, Clayton, VIC 3800, Australia
- Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, VIC 3004, Australia
| | - John Stenos
- Australian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, VIC 3220, Australia
| | - Stephen Graves
- Australian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, VIC 3220, Australia
| | - Charlotte L. Oskam
- Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, WA 6150, Australia
| | - Una M. Ryan
- Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia
| | - Peter J. Irwin
- Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Murdoch, WA 6150, Australia
| |
Collapse
|